Groundbreaking $18.5 Billion Collaboration! Stone Pharmaceutical Group Teams up with AstraZeneca to Compete in Weight-Loss Market

This Data Is Locked!

This area is available only to Subscribers.

Stone Pharmaceutical Group (1093.HK) announced before market open on January 30th that it has signed a strategic R&D cooperation and authorization agreement with AstraZeneca. The... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?